{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:30:34Z","timestamp":1791379834233,"version":"4.3.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008108","name":"Taipei Tzu Chi Hospital","doi-asserted-by":"publisher","award":["TCRD-TPE-111-9"],"award-info":[{"award-number":["TCRD-TPE-111-9"]}],"id":[{"id":"10.13039\/501100008108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014716","name":"Buddhist Tzu Chi Hospital","doi-asserted-by":"publisher","award":["TCMF-A110-05(113)"],"award-info":[{"award-number":["TCMF-A110-05(113)"]}],"id":[{"id":"10.13039\/501100014716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12072-024-10769-0","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T10:06:36Z","timestamp":1736071596000},"page":"415-427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genetic predisposition of metabolic dysfunction-associated steatotic liver disease: a population-based genome-wide association study"],"prefix":"10.1007","volume":"19","author":[{"given":"Shao-Wen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Han","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0827-4503","authenticated-orcid":false,"given":"Chia-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,5]]},"reference":[{"issue":"6","key":"10769_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u20131986","journal-title":"Hepatology"},{"key":"10769_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384","journal-title":"Hepatology"},{"issue":"2 Suppl 1","key":"10769_CR3","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43(2 Suppl 1):S99\u2013S112","journal-title":"Hepatology"},{"key":"10769_CR4","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/hep.23594","volume":"51","author":"BQ Starley","year":"2010","unstructured":"Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51:1820\u20131832","journal-title":"Hepatology"},{"key":"10769_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4103\/ijem.IJEM_585_17","volume":"22","author":"M Dharmalingam","year":"2018","unstructured":"Dharmalingam M, Yamasandhi PG. Nonalcoholic fatty liver disease and type 2 diabetes mellitus. Indian J Endocrinol Metab. 2018;22:421\u2013428","journal-title":"Indian J Endocrinol Metab"},{"issue":"Suppl 1","key":"10769_CR6","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1111\/apt.17930","volume":"59","author":"SK Bansal","year":"2024","unstructured":"Bansal SK, Bansal MB. Pathogenesis of MASLD and MASH\u2014role of insulin resistance and lipotoxicity. Aliment Pharmacol Ther. 2024;59(Suppl 1):S10\u2013S22. https:\/\/doi.org\/10.1111\/apt.17930","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10769_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/biomedicines11010106","volume":"11","author":"SA Sulaiman","year":"2022","unstructured":"Sulaiman SA, Dorairaj V, Adrus MNH. Genetic polymorphisms and diversity in nonalcoholic fatty liver disease (NAFLD): a mini review. Biomedicines. 2022;11(1):106","journal-title":"Biomedicines"},{"key":"10769_CR8","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41588-023-01497-6","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen Y, Du X, Kuppa A, Feitosa MF, Bielak LF, O\u2019Connell JR, et al. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. Nat Genet. 2023;55:1640\u20131650","journal-title":"Nat Genet"},{"key":"10769_CR9","doi-asserted-by":"publisher","first-page":"100437","DOI":"10.1016\/j.xcrm.2021.100437","volume":"2","author":"N Ghodsian","year":"2021","unstructured":"Ghodsian N, Abner E, Emdin CA, Gobeil \u00c9, Taba N, Haas ME, et al. Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. Cell Rep Med. 2021;2:100437","journal-title":"Cell Rep Med"},{"issue":"1","key":"10769_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jfma.2023.07.010","volume":"123","author":"KL Cheng","year":"2024","unstructured":"Cheng KL, Wang SW, Cheng YM, Hsieh TH, Wang CC, Kao JH. Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease. J Formos Med Assoc. 2024;123(1):36\u201344","journal-title":"J Formos Med Assoc"},{"key":"10769_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2217\/14622416.9.2.235","volume":"9","author":"CT Fan","year":"2008","unstructured":"Fan CT, Lin JC, Lee CH. Taiwan biobank: a project aiming to aid taiwan\u2019s transition into a biomedical island. Pharmacogenomics. 2008;9:235\u2013246","journal-title":"Pharmacogenomics"},{"key":"10769_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix110","volume":"7","author":"JC Lin","year":"2018","unstructured":"Lin JC, Fan CT, Liao CC, Chen YS. Taiwan biobank: making cross-database convergence possible in the big data era. Gigascience. 2018;7:1\u20134","journal-title":"Gigascience"},{"issue":"11","key":"10769_CR13","doi-asserted-by":"publisher","first-page":"100197","DOI":"10.1016\/j.xgen.2022.100197","volume":"2","author":"YA Feng","year":"2022","unstructured":"Feng YA, Chen CY, Chen TT, Kuo PH, Hsu YH, Yang HI, et al. Taiwan Biobank: a rich biomedical research database of the Taiwanese population. Cell Genom. 2022;2(11):100197","journal-title":"Cell Genom"},{"key":"10769_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10769_CR15","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846\u2013854","journal-title":"Hepatology"},{"issue":"20","key":"10769_CR16","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.3390\/jcm10204628","volume":"10","author":"A Kab\u0142ak-Ziembicka","year":"2021","unstructured":"Kab\u0142ak-Ziembicka A, Przew\u0142ocki T. Clinical significance of carotid intima-media complex and carotid plaque assessment by ultrasound for the prediction of adverse cardiovascular events in primary and secondary care patients. J Clin Med. 2021;10(20):4628","journal-title":"J Clin Med"},{"issue":"6","key":"10769_CR17","doi-asserted-by":"publisher","first-page":"e38322","DOI":"10.1371\/journal.pone.0038322","volume":"7","author":"T Kawaguchi","year":"2012","unstructured":"Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE. 2012;7(6):e38322","journal-title":"PLoS ONE"},{"issue":"2","key":"10769_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.14218\/JCTH.2021.00067","volume":"10","author":"K Xu","year":"2022","unstructured":"Xu K, Zheng KI, Zhu PW, Liu WY, Ma HL, Li G, et al. Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 increases susceptibility to nonalcoholic steatohepatitis. J Clin Transl Hepatol. 2022;10(2):219\u2013229","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"10769_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5009\/gnl17306","volume":"12","author":"GE Chung","year":"2018","unstructured":"Chung GE, Lee Y, Yim JY, Choe EK, Kwak MS, Yang JI, et al. Genetic polymorphisms of PNPLA3 and SAMM50 are associated with nonalcoholic fatty liver disease in a Korean population. Gut Liver. 2018;12(3):316\u2013323","journal-title":"Gut Liver"},{"issue":"1","key":"10769_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2010.10.024","volume":"55","author":"C Dubuquoy","year":"2011","unstructured":"Dubuquoy C, Robichon C, Lasnier F, Langlois C, Dugail I, Foufelle F, et al. Distinct regulation of adiponutrin\/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes. J Hepatol. 2011;55(1):145\u2013153","journal-title":"J Hepatol"},{"issue":"1","key":"10769_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12902-021-00789-4","volume":"21","author":"N Salari","year":"2021","unstructured":"Salari N, Darvishi N, Mansouri K, Ghasemi H, Hosseinian-Far M, Darvishi F, et al. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis. BMC Endocr Disord. 2021;21(1):125","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"10769_CR22","first-page":"175","volume":"4","author":"H Salameh","year":"2016","unstructured":"Salameh H, Hanayneh MA, Masadeh M, Naseemuddin M, Matin T, Erwin A, et al. PNPLA3 as a genetic determinant of risk for and severity of non-alcoholic fatty liver disease spectrum. J Clin Transl Hepatol. 2016;4(3):175\u2013191","journal-title":"J Clin Transl Hepatol"},{"key":"10769_CR23","doi-asserted-by":"publisher","first-page":"e14324","DOI":"10.1097\/MD.0000000000014324","volume":"98","author":"G Dai","year":"2019","unstructured":"Dai G, Liu P, Li X, Zhou X, He S. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: a meta-analysis. Medicine (Baltimore). 2019;98:e14324","journal-title":"Medicine (Baltimore)"},{"key":"10769_CR24","doi-asserted-by":"publisher","first-page":"9284","DOI":"10.1038\/srep09284","volume":"5","author":"R Xu","year":"2015","unstructured":"Xu R, Tao A, Zhang S, Deng Y, Chen G. Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis. Sci Rep. 2015;5:9284","journal-title":"Sci Rep"},{"issue":"11","key":"10769_CR25","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.2337\/db09-0279","volume":"58","author":"K Kantartzis","year":"2009","unstructured":"Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, K\u00f6nigsrainer I, et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes. 2009;58(11):2616\u20132623","journal-title":"Diabetes"},{"issue":"12","key":"10769_CR26","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1111\/liv.15438","volume":"42","author":"M Holmer","year":"2022","unstructured":"Holmer M, Ekstedt M, Nasr P, Zenlander R, Wester A, Tavaglione F, et al. Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up. Liver Int. 2022;42(12):2769\u20132780","journal-title":"Liver Int"},{"issue":"7","key":"10769_CR27","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/2211-5463.13146","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Shen W, Wu G, Qin C, Zhang Y, Wang Y, et al. The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms. FEBS Open Bio. 2021;11(7):1893\u20131906","journal-title":"FEBS Open Bio"},{"key":"10769_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16521","author":"KJ Lee","year":"2024","unstructured":"Lee KJ, Moon JS, Lim JG, Huh H, Ahn JE, Kim L, et al. PARVB and HSD17B13 variants are associated with nonalcoholic fatty liver disease in children. J Gastroenterol Hepatol. 2024. https:\/\/doi.org\/10.1111\/jgh.16521","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10769_CR29","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.3390\/biomedicines11092416","volume":"11","author":"J Zhao","year":"2023","unstructured":"Zhao J, Xu X, Wei X, Zhang S, Xu H, Wei X, et al. SAMM50-rs2073082, -rs738491 and -rs3761472 interactions enhancement of susceptibility to non-alcoholic fatty liver disease. Biomedicines. 2023;11(9):2416","journal-title":"Biomedicines"},{"issue":"10","key":"10769_CR30","doi-asserted-by":"publisher","first-page":"e31076","DOI":"10.5812\/hepatmon.31076","volume":"15","author":"L Chen","year":"2015","unstructured":"Chen L, Lin Z, Jiang M, Lu L, Zhang H, Xin Y, et al. Genetic variants in the SAMM50 gene create susceptibility to nonalcoholic fatty liver disease in a Chinese Han population. Hepat Mon. 2015;15(10):e31076","journal-title":"Hepat Mon"},{"key":"10769_CR31","doi-asserted-by":"publisher","first-page":"145431","DOI":"10.1016\/j.gene.2021.145431","volume":"775","author":"A Chatterjee","year":"2021","unstructured":"Chatterjee A, Basu A, Das K, Chowdhury A, Basu P. Exome-wide scan identifies significant association of rs4788084 in IL27 promoter with increase in hepatic fat content among Indians. Gene. 2021;775:145431","journal-title":"Gene"},{"issue":"7","key":"10769_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00439-013-1294-3","volume":"132","author":"T Kitamoto","year":"2013","unstructured":"Kitamoto T, Kitamoto A, Yoneda M, Hyogo H, Ochi H, Nakamura T, et al. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum Genet. 2013;132(7):783\u2013792","journal-title":"Hum Genet"},{"issue":"29","key":"10769_CR33","doi-asserted-by":"publisher","first-page":"e29958","DOI":"10.1097\/MD.0000000000029958","volume":"101","author":"M Qiao","year":"2022","unstructured":"Qiao M, Yang JH, Zhu Y, Hu JP. Association of sorting and assembly machinery component 50 homolog gene polymorphisms with nonalcoholic fatty liver disease susceptibility. Medicine (Baltimore). 2022;101(29):e29958","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10769_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.crad.2019.02.014","volume":"74","author":"ML Kromrey","year":"2019","unstructured":"Kromrey ML, Ittermann T, Berning M, Kolb C, Hoffmann RT, Lerch MM, et al. Accuracy of ultrasonography in the assessment of liver fat compared with MRI. Clin Radiol. 2019;74(7):539\u2013546","journal-title":"Clin Radiol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10769-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T01:36:10Z","timestamp":1744767370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10769-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10769"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10769-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5187928\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,5]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Shao-Wen Wang, Ching Wang, Yu-Ming Cheng, Chun-Yi Chen, Tsung-Han Hsieh, Chia-Chi Wang and Jia-Horng Kao declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}